Cost-effectiveness analysis of a randomized clinical trial of early versus deferred endovenous ablation of superficial venous reflux in patients with venous ulceration.
David M EpsteinM S GohelF HeatleyX LiuA BradburyR BulbuliaN CullumI NyamekyeK R PoskittS RentonJ WarwickAlun Huw Daviesnull nullPublished in: The British journal of surgery (2019)
Early treatment of superficial reflux is highly likely to be cost-effective in patients with venous leg ulcers over 1 year. Registration number: ISRCTN02335796 (http://www.isrctn.com).
Keyphrases